Retrospective study to describe prevalence of hyperkalemia in Russian population based on large laboratory network (HEKATE)

Trial Identifier:	D1843R00280
Sponsor:	AstraZeneca
NCTID::	NCT03657875
Start Date:	September 2017
Primary Completion Date:	September 2017
Study Completion Date:	September 2017

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Russia	Moscow, Russia

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.